QOIN news

Latest 1 stories · newest Nov 4, 2026

QOIN

Quoin Pharmaceuticals extends sales agreement

Quoin Pharmaceuticals entered into a sales agreement with Leerink Partners and launched an S-3 registration statement to sell ADSs. The registration could provide ongoing equity financing access for the company.

Offering Nov 4, 2026 sentiment +0.20 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same QOIN feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/QOIN/newsSTART FREE